Biktarvy, formally known as bictegravir, includes a powerful single-tablet regimen for treating HIV infection. This formula integrates three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to copy within the body, remarkably lowering the viral quantity. For many